

Cover Story
Free
This series re-examines the concurrent controversies at the Cancer Prevention and Research Institute of Texas and MD Anderson Cancer Center. This examination is possible in part because of new insight provided by Alfred Gilman, a Nobel laureate who served as the first scientific director of the state institution that distributes $300 million a year. Gilman died on Dec. 23, 2015.
In Brief


Drugs & Targets
Trending Stories
- In first NCAB director’s report, Anthony Letai focuses on centralized grant review, budget outlook
- Pazdur leaves FDA after 25-year career that shaped the agency’s oncology regulations
BIO calls for the end of “constant turmoil,” urges the administration to “right the ship” - Montefiore Einstein Director Edward Chu dies of glioblastoma at 66
- Anthony Letai pledges to ensure stability for extramural and intramural cancer science
- Mary Pazdur, 63, Dies of Cancer; What Her Husband Has Learned
- Tidmarsh is out, Pazdur is in: FDA’s CDER under new leadership











